Warshawsky T
Can Commun Dis Rep. 2019; 39(ACS-1):1-40.
PMID: 31697281
PMC: 6802440.
DOI: 10.14745/ccdr.v39i00a01.
Findlow H, Tapia M, Sow S, Haidara F, Coulibaly F, Keita A
Vaccine. 2019; 37(18):2477-2481.
PMID: 30952500
PMC: 6990398.
DOI: 10.1016/j.vaccine.2019.03.045.
Gonzalez-Miro M, Rodriguez-Noda L, Farinas-Medina M, Cedre-Marrero B, Madariaga-Zarza S, Zayas-Vignier C
Sci Rep. 2018; 8(1):1888.
PMID: 29382864
PMC: 5789850.
DOI: 10.1038/s41598-018-20205-7.
Bastos R, Correa M, de Souza I, da Silva M, Pereira D, Martins F
Glycoconj J. 2017; 35(1):3-13.
PMID: 28929266
DOI: 10.1007/s10719-017-9787-2.
Weissmueller N, Marsay L, Schiffter H, Carlisle R, Rollier C, Prudhomme R
PLoS One. 2017; 12(8):e0183427.
PMID: 28837693
PMC: 5570268.
DOI: 10.1371/journal.pone.0183427.
Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone.
Broderick M, Romero-Steiner S, Rajam G, Johnson S, Milton A, Kim E
Clin Vaccine Immunol. 2016; 23(8):672-80.
PMID: 27280619
PMC: 4979175.
DOI: 10.1128/CVI.00267-16.
Observed parent-child relationship quality predicts antibody response to vaccination in children.
OConnor T, Wang H, Moynihan J, Wyman P, Carnahan J, Lofthus G
Brain Behav Immun. 2015; 48:265-73.
PMID: 25862953
PMC: 4508214.
DOI: 10.1016/j.bbi.2015.04.002.
Depressive symptoms and immune response to meningococcal conjugate vaccine in early adolescence.
OConnor T, Moynihan J, Wyman P, Carnahan J, Lofthus G, Quataert S
Dev Psychopathol. 2014; 26(4 Pt 2):1567-76.
PMID: 25422979
PMC: 5771474.
DOI: 10.1017/S0954579414001242.
Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel.
Patel M, Romero-Steiner S, Broderick M, Thomas C, Plikaytis B, Schmidt D
Vaccine. 2014; 32(30):3805-9.
PMID: 24837781
PMC: 5748241.
DOI: 10.1016/j.vaccine.2014.05.001.
Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage.
Alamro M, Bidmos F, Chan H, Oldfield N, Newton E, Bai X
Infect Immun. 2014; 82(6):2472-84.
PMID: 24686058
PMC: 4019173.
DOI: 10.1128/IAI.01521-14.
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.
Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C
Nat Immunol. 2013; 15(2):195-204.
PMID: 24336226
PMC: 3946932.
DOI: 10.1038/ni.2789.
CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infection.
Westrop S, Moyle G, Jackson A, Nelson M, Mandalia S, Imami N
Mol Med. 2012; 18:1240-8.
PMID: 22875102
PMC: 3510292.
DOI: 10.2119/molmed.2012.00206.
Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine.
Moore C, Hennig B, Perrett K, Hoe J, Lee S, Fletcher H
Clin Vaccine Immunol. 2011; 19(3):295-303.
PMID: 22205660
PMC: 3294616.
DOI: 10.1128/CVI.05379-11.
Concomitant administration of Mycobacterium bovis BCG with the meningococcal C conjugate vaccine to neonatal mice enhances antibody response and protective efficacy.
Brynjolfsson S, Bjarnarson S, Mori E, Del Giudice G, Jonsdottir I
Clin Vaccine Immunol. 2011; 18(11):1936-42.
PMID: 21900528
PMC: 3209029.
DOI: 10.1128/CVI.05247-11.
Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assay.
Poolman J, De Vleeschauwer I, Durant N, Devos N, Feron C, Lestrate P
Clin Vaccine Immunol. 2011; 18(7):1108-17.
PMID: 21593240
PMC: 3147334.
DOI: 10.1128/CVI.00549-10.
Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants.
Holder B, Miles D, Kaye S, Crozier S, Mohammed N, Duah N
PLoS One. 2010; 5(11):e14013.
PMID: 21103338
PMC: 2984441.
DOI: 10.1371/journal.pone.0014013.
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C....
Borrow R, Andrews N, Findlow H, Waight P, Southern J, Crowley-Luke A
Clin Vaccine Immunol. 2009; 17(1):154-9.
PMID: 19906895
PMC: 2812092.
DOI: 10.1128/CVI.00384-09.
Purified capsular polysaccharide of Neisseria meningitidis serogroup A as immune potentiator for antibody production.
Menendez T, Carmenate T, Cruz-Leal Y, Coizeau E, Caballero E, Bello D
Curr Microbiol. 2009; 60(2):79-84.
PMID: 19771476
DOI: 10.1007/s00284-009-9505-9.
Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults.
Findlow H, Plikaytis B, Aase A, Bash M, Chadha H, Elie C
Clin Vaccine Immunol. 2009; 16(7):969-77.
PMID: 19474264
PMC: 2708411.
DOI: 10.1128/CVI.00068-09.
Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.
Kelly D, Snape M, Perrett K, Clutterbuck E, Lewis S, Blanchard Rohner G
Immunology. 2009; 127(1):134-43.
PMID: 19175802
PMC: 2678189.
DOI: 10.1111/j.1365-2567.2008.02934.x.